Braza Discusses eSports, Foley Survey in San Francisco Business Times
02 August 2018
San Francisco Business Times
Partner Mary K. Braza was quoted in a San Francisco Business Times article, “Esports Joins the Big Leagues,” about how and why professional sports teams like the Golden State Warriors are investing in esports.
“A lot of it depends on the type of owner you have in the traditional sports,” said Braza, who co-chairs Foley’s sports industry team. “The Warriors owners are more interested in new technologies, they’re younger than a lot of owners and they’re more connected to the tech community.”
The article also noted the findings of Foley and The Esports Observer’s new esports survey including concerns about match fixing, net neutrality and illegal gambling.
“A lot of it depends on the type of owner you have in the traditional sports,” said Braza, who co-chairs Foley’s sports industry team. “The Warriors owners are more interested in new technologies, they’re younger than a lot of owners and they’re more connected to the tech community.”
The article also noted the findings of Foley and The Esports Observer’s new esports survey including concerns about match fixing, net neutrality and illegal gambling.
People
Related News
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."
14 February 2025
In the News
Christopher Swift Comments on FCPA Enforcement Pause
Foley & Lardner LLP partner Christopher Swift commented on the Trump administration's executive order pausing enforcement of the Foreign Corrupt Practices Act in The New York Times article, "Moves by Trump and Bondi Raise Hopes of Those Accused of Foreign Corruption."
13 February 2025
In the News
Nikhil Pradhan on FDA Draft AI Drug Guidance – 'The industry is very much evolving'
Foley & Lardner LLP senior counsel Nikhil Pradhan shared insight on recent draft guidance from the U.S. Food and Drug Administration's in the MedCentral article, "FDA Draft Guidance Addresses Drug Submissions that Use AI Data."